In accordance with the latter hypothesis, in the present study we showed that miR-101 effectively prevents liver tumor development initiated by c-Myc and AKT/Ras oncogenes, providing strong evidence that miR-101 may be an ideal candidate for miRNA-based chemoprevention of HCC. The gene discussed is AKT1; the disease is hepatocellular carcinoma.